Ali Ayhan

Ali Ayhan

Auto-generated profile, based on publicly available information

Ali Ayhan

School of Medicine, Department of Obstetrics and Gynecology, Başkent University, Bahçelievler, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
KAKoray Aslan
Koray Aslan
MMMehmet Mutlu Meydanli
Mehmet Mutlu Meydanli
MÖMurat ÖZ
Murat ÖZ
YTYusuf Aytaç Tohma
Yusuf Aytaç Tohma
AHAli Haberal
Ali Haberal
AAAli Ayhan
Ali Ayhan
The aim of this study was to determine the prognostic value of lymph node ratio (LNR) in women with 2018 International Federation of Gynecology and Obstetrics stage IIIC cervical cancer. In this retrospective dual-institutional study, a total of 185 node-positive cervical cancer patients who had undergone radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy were included. All of the patients received adjuvant chemoradiation after surgery. LNR was defined as the ratio of positive lymph nodes (LNs) to the total number of LNs removed. The patients were categorized into 2 groups according to LNR; LNR <0.05 and LNR ≥0.05. The prognostic value of LNR was evaluated with univariate log-rank tests and multivariate Cox regression models. A total of 138 patients (74.6%) had stage IIIC1 disease and 47 (25.4%) patients had stage IIIC2 disease. With a median follow-up period of 45.5 months (range 3-135 months), the 5-year disease-free survival (DFS) rate was 62.5% whereas the 5-year overall survival (OS) rate was 70.4% for the entire study population. The 5-year DFS rates for LNR <0.05 and LNR ≥0.05 were 78.2%, and 48.4%, respectively (p<0.001). Additionally, the 5-year OS rates for LNR <0.05 and LNR ≥0.05 were 80.6%, and 61.2%, respectively (p=0.007). On multivariate analysis, LNR ≥0.05 was associated with a worse DFS (hazard ratio [HR]=2.12; 95% confidence interval [CI]=1.15-3.90; p=0.015) and OS (HR=1.95; 95% CI=1.01-3.77; p=0.046) in women with stage IIIC cervical cancer. LNR ≥0.05 seems to be an independent prognostic factor for decreased DFS and OS in stage IIIC cervical carcinoma.

1 January 2019 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
HŞHanifi Şahin
Hanifi Şahin
FKFunda Karatas
Funda Karatas
GSGonca Coban Serbetcioglu
Gonca Coban Serbetcioglu
ÖÖÖzlem Özen
Özlem Özen
ÖEÖzlem Erdem
Özlem Erdem
AAAli Ayhan
Ali Ayhan
Şahin H, et al. J Gynecol Oncol. 2018 Aug;30:e54. https://doi.org/10.3802/jgo.2019.30.e54

1 January 2017 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
VKVakkas Korkmaz
Vakkas Korkmaz
MMMehmet Mutlu Meydanli
Mehmet Mutlu Meydanli
IYIbrahim Yalçın
Ibrahim Yalçın
MSMustafa Erkan Sarı
Mustafa Erkan Sarı
HSHanifi Sahin
Hanifi Sahin
AAAli Ayhan
Ali Ayhan
Korkmaz V, et al. J Gynecol Oncol. 2017 Jul;28(6):e78. https://doi.org/10.3802/jgo.2017.28.e78

1 September 2019 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
AAAli Ayhan
Ali Ayhan
KAKoray Aslan
Koray Aslan
AAAYCA NAZLI AKAR
AYCA NAZLI AKAR
HAHuseyin Akilli
Huseyin Akilli
MÖMurat ÖZ
Murat ÖZ
MMMehmet Mutlu Meydanli
Mehmet Mutlu Meydanli

1 January 2020 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
AYAyçağ Yorgancı
Ayçağ Yorgancı
MMMehmet Mutlu Meydanlı
Mehmet Mutlu Meydanlı
NKNEZAKET KADIOĞLU
NEZAKET KADIOĞLU
STSalih Taşkın
Salih Taşkın
FKFulya Kayıkçıoğlu
Fulya Kayıkçıoğlu
AAAli Ayhan
Ali Ayhan

16 November 2017 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
IYIbrahim Yalcin
Ibrahim Yalcin
MMMehmet Mutlu Meydanli
Mehmet Mutlu Meydanli
ATAhmet Taner Turan
Ahmet Taner Turan
STSalih Taskin
Salih Taskin
MSMustafa Erkan Sari
Mustafa Erkan Sari
AAAli Ayhan
Ali Ayhan